These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18678433)

  • 1. Molecular tools and hepatocellular carcinoma: Adding help or confusion in liver transplantation?
    Vibert E; Samuel D
    J Hepatol; 2008 Oct; 49(4):498-501. PubMed ID: 18678433
    [No Abstract]   [Full Text] [Related]  

  • 2. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma.
    Reddy MS; Manas DM
    Transplantation; 2007 Feb; 83(3):367-8. PubMed ID: 17297420
    [No Abstract]   [Full Text] [Related]  

  • 3. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival.
    Marsh JW; Finkelstein SD; Demetris AJ; Swalsky PA; Sasatomi E; Bandos A; Subotin M; Dvorchik I
    Liver Transpl; 2003 Jul; 9(7):664-71. PubMed ID: 12827550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular markers and hepatocellular carcinoma: lending a helping hand in liver transplantation?
    Dai Z; Yu L; Zhou J; Qiu SJ; Fan J
    Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):211-3. PubMed ID: 19485802
    [No Abstract]   [Full Text] [Related]  

  • 5. [Liver transplantation for hepatocellular carcinoma].
    Tanaka A; Tanaka K; Kaihara S; Ueda M; Uemoto S; Kiuchi T; Egawa H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():705-16. PubMed ID: 11762042
    [No Abstract]   [Full Text] [Related]  

  • 6. [Strategy to improve the prognosis of liver transplantation for hepatocellular carcinoma].
    Fan J; Xu Y
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1602-5. PubMed ID: 19094749
    [No Abstract]   [Full Text] [Related]  

  • 7. [Expression of SOX4 gene and early recurrence of hepatocellular carcinoma: their relationship and the clinical significance].
    Zheng JH; Jian ZX; Jin HS; Chen SC; Wang GY
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):818-9. PubMed ID: 20423819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation.
    Yang Z; Zhou L; Wu LM; Lai MC; Xie HY; Zhang F; Zheng SS
    Ann Surg Oncol; 2011 May; 18(5):1243-50. PubMed ID: 21327457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transplantation and liver resection for hepatocellular carcinoma in cirrhosis].
    Benckert C; Thelen A; Mittler J; Jonas S; Neuhaus P
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S245-7. PubMed ID: 16435728
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver transplantation in a 27-year-old female with familial HBsAg-positive hepatocellular carcinoma.
    Macdougall BR; Johnson PJ; Williams R; Strunin L; Macmaster P; Calne RY; Bronkhorst FB; Katchaki JN; Brandt KH; Houthoff HJ; Piers DA; Schuur KH; Krom RA; Gips CH
    Neth J Med; 1978; 21(3):101-16. PubMed ID: 78459
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers.
    Schwartz M; Dvorchik I; Roayaie S; Fiel MI; Finkelstein S; Marsh JW; Martignetti JA; Llovet JM
    J Hepatol; 2008 Oct; 49(4):581-8. PubMed ID: 18602719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A marker for predictions of HCC recurrence postresection?
    Blendis L; Wong F
    Gastroenterology; 2002 Dec; 123(6):2152-3. PubMed ID: 12454875
    [No Abstract]   [Full Text] [Related]  

  • 13. Can the prognosis of liver transplantation for hepatocellular carcinoma be predicted?
    Ringe B
    Hepatology; 1997 Aug; 26(2):507-8. PubMed ID: 9252168
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver resection and liver transplantation in hepatocellular carcinoma.
    Franco D
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S94. PubMed ID: 8986104
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence.
    Singhal A; Jayaraman M; Dhanasekaran DN; Kohli V
    Crit Rev Oncol Hematol; 2012 May; 82(2):116-40. PubMed ID: 21680198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Another key molecule for pathogenesis of hepatocellular carcinoma.
    Tada M; Omata M
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1803-4. PubMed ID: 20002936
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
    Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of recurrent hepatocellular carcinoma after liver transplantation.
    Davis E; Wiesner R; Valdecasas J; Kita Y; Rossi M; Schwartz M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S162-6. PubMed ID: 21688382
    [No Abstract]   [Full Text] [Related]  

  • 19. Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma.
    Marsh JW; Casavilla A; Iwatsuki S; Dvorchik I; Subotin M; Balan V; Rakela J; Subbotin V; Popechitelev EP
    Hepatology; 1997 Dec; 26(6):1689-91. PubMed ID: 9398022
    [No Abstract]   [Full Text] [Related]  

  • 20. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
    Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.